2901. Omalizumab for the Treatment of Multiple Food Allergies.
作者: Robert A Wood.;Alkis Togias.;Scott H Sicherer.;Wayne G Shreffler.;Edwin H Kim.;Stacie M Jones.;Donald Y M Leung.;Brian P Vickery.;J Andrew Bird.;Jonathan M Spergel.;Ahmar Iqbal.;Julie Olsson.;Monica Ligueros-Saylan.;Alkaz Uddin.;Agustin Calatroni.;Charmaine Marquis Huckabee.;Nicole H Rogers.;Nancy Yovetich.;Jennifer Dantzer.;Kim Mudd.;Julie Wang.;Marion Groetch.;David Pyle.;Corinne A Keet.;Michael Kulis.;Sayantani B Sindher.;Andrew Long.;Amy M Scurlock.;Bruce J Lanser.;Tricia Lee.;Christopher Parrish.;Terri Brown-Whitehorn.;Amanda K Rudman Spergel.;Maria Veri.;Sanaz Daneshfar Hamrah.;Erica Brittain.;Julian Poyser.;Lisa M Wheatley.;R Sharon Chinthrajah.
来源: N Engl J Med. 2024年390卷10期889-899页
Food allergies are common and are associated with substantial morbidity; the only approved treatment is oral immunotherapy for peanut allergy.
2909. Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
作者: Michael E Wechsler.;Parameswaran Nair.;Benjamin Terrier.;Bastian Walz.;Arnaud Bourdin.;David R W Jayne.;David J Jackson.;Florence Roufosse.;Lena Börjesson Sjö.;Ying Fan.;Maria Jison.;Christopher McCrae.;Sofia Necander.;Anat Shavit.;Claire Walton.;Peter A Merkel.; .
来源: N Engl J Med. 2024年390卷10期911-921页
Eosinophilic granulomatosis with polyangiitis (EGPA) is a vasculitis characterized by eosinophilic inflammation. Benralizumab, a monoclonal antibody against the interleukin-5α receptor expressed on eosinophils, may be an option for treating EGPA.
|